Search results for:
Photodisinfection cuts COVID in meat processing plant
Newly published results show treatment with Ondine’s nasal photodisinfection dramatically reduced COVID-19 rates at Canadian meat processing plant Vancouver, British Columbia, Canada - June 22, 2023 (updated with corrections August 16, 2023) Weekly nasal photodisinfection of 1,500 workers in a meat processing plant in [...]
Nature publication: Ondine’s therapy suppresses SARS2 in COVID-19 patients
Nature publication reports that Ondine’s nasal antimicrobial photodynamic disinfection therapy suppresses SARS-CoV-2 in COVID-19 patients Vancouver, British Columbia, Canada - August 31, 2022 The Toronto-based research reports a decrease of viral infectivity of 90% of SARS-CoV-2 patient samples using Ondine’s nasal antimicrobial photodynamic disinfection (aPDT), [...]
Ondine completes enrollment for US Phase II nasal photodisinfection trial
Ondine Biomedical completes patient recruitment for US Phase II nasal photodisinfection trial Vancouver, British Columbia, Canada - August 8, 2022 Ondine Biomedical Inc. (LON: OBI), has recruited the final patient to its nasal photodisinfection exploratory Phase 2 trial. The trial is evaluating how effectively Ondine’s [...]
Successful SARS-CoV-2 trial with Ondine’s nasal photodisinfection
Suppression of SARS-CoV-2 replication and infectivity in vaccinated individuals: a clinical study of Ondine Biomedical’s nasal photodisinfection carried out at the Clínica Universidad de Navarra, Spain Vancouver, British Columbia, Canada - July 19, 2022 Clínica Universidad de Navarra has completed a randomised controlled study of Ondine [...]
Ondine COVID-19 clinical trial in Spain begins patient recruitment
Ondine Biomedical Inc. and University of Navarra in Spain initiate clinical trial deploying nasal photodisinfection for a new variant-agnostic approach to stop SARS-CoV-2 replication in high-risk viral carriers Vancouver, British Columbia, Canada - December 20, 2021 Nasal decolonisation therapy, Steriwave™, destroys all pathogen classes, including [...]
Ondine appoints Professor Trevor Jones to lead COVID-19 advisory board
Ondine Biomedical appoints Professor Trevor Jones to lead COVID-19 advisory board Vancouver, British Columbia, Canada - December 15, 2021 AIM listed life sciences company, Ondine Biomedical, has appointed Professor Trevor Jones CBE FMedSci to lead a new advisory board on the use of its pioneering [...]
Ondine Receives Innovation Award of Excellence at ICPIC 2021
Ondine Receives Innovation Award of Excellence at World-leading Infection Conference, ICPIC 2021, for Photodisinfection Efficacy Results against COVID-19 Virus Variants including Delta Ondine’s nasal photodisinfection technology has been shown to eliminate the RNA signature of SARS-CoV-2, including the dominant Delta variant, in in vitro research. The research [...]
Preventing COVID-19 with Photodisinfection
Preventing COVID-19 with Photodisinfection – New Results Presented at European Society of Photobiology Results presented at 2021 European Society of Photobiology conference demonstrate Ondine’s broad-spectrum nasal photodisinfection technology eliminates COVID at both genomic and spike protein levels. Nasal decolonization is recommended by the [...]
For Media Information
Simon Vane Percy
Amanda Bernard
